Penerapan Metode Targeted Sequencing pada Penyakit Kanker

Rahmawati Latif, Yusminah Hala


Abstract


The purpose of this study is to examine the application of the Targeted Sequencing method for various types of cancer. This research uses a literature review method, involving the collection, analysis, and synthesis of relevant scientific sources to answer the research question. The results of the study, based on the literature approach, indicate that Targeted Sequencing is an alternative for detecting and identifying cancer, making it easier to determine appropriate treatments and therapies. Targeted Sequencing has significant potential in the personalization of cancer treatment. However, challenges such as tumor heterogeneity, panel limitations, high costs, and clinical validation need to be addressed to ensure maximum benefits for patients. Collaboration among genomic experts, clinicians, and researchers is necessary to overcome these obstacles.

Keywords


Targeted Sequencing, Cancer

References


American Cancer Society: Cancer Facts & Figures, (2013). American Cancer Society Inc., http://www.cancer.org, Atlanta.

Bandoh, N., Akahane, T., Goto, T., Kono, M., Ichikawa, H., Sawada, & Nishihara, H. (2018). Targeted next generation sequencing of cancer related genes in thyroid carcinoma: A single institution's experience. Oncology Letters, 16(6), 7278-7286.

Bewicke-Copley, F., Kumar, E. A., Palladino, G., Korfi, K., & Wang, J. (2019). Applications and analysis of targeted genomic sequencing in cancer studies. Computational and structural biotechnology journal, 17, 1348-1359.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2018). CA Cancer J Clin.;68:394-424.

Cai, H.; Jing, C.; Chang, X.; Ding, D.; Han, T.; Yang, J.; Lu, Z.; Hu, X.; Liu, Z.; Wang, J.; et al. (2019) Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J. Transl. Med, 17, 189.

Cardarella S, Ogino A, Nishino M, Butaney M, Shen J, Lydon C, et al. (2013) Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. Clin Cancer Res;19:4532–40. https://doi.org/10.1158/ 1078-0432.CCR-13-0657.

Chin, Y. M., Takahashi, Y., Chan, H. T., Otaki, M., Fujishima, M., Shibayama, & Low, S. K. (2021). Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer. Cancer Science, 112(1), 454-464.

Feng, H., Wang, X., Zhang, Z., Tang, C., Ye, H., Jones & Liu, D. (2015). Identification of genetic mutations in human lung cancer by targeted sequencing. Cancer Informatics, 14, CIN-S22941.

Ferlay J, Soerjomataram I, Ervik M, et al. (2014), GLOBOCAN 2012 v1.0, Cancer Inci- dence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http:// globocan.iarc.fr. Accessed May 5.

Gerber TS, Schad A, Hartmann N, Springer E, Zechner U and Musholt TJ, (2018) Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer. Endocr Connect 7: 47-55.

Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. (2012). A landscape of driver mutations in melanoma. Cell 2012;150:251–63. https:// doi.org/10.1016/j.cell.2012.06.024.

Jeon MJ, Chun SM, Kim D, Kwon H, Jang EK, Kim TY, Kim WB, Shong YK, Jang SJ, Song DE and Kim WG. (2016) Genomic alterations of anaplastic thyroid carcinoma detected by targeted massive parallel sequencing in a BRAF (V600E) mutation‐prevalent area. Thyroid 26: 683‐690.

Song, H., Dicks, E. M., Tyrer, J., Intermaggio, M., Chenevix-Trench, G., Bowtell, D. D., ... & OPAL Study Group. (2021). Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer. Journal of medical genetics, 58(5), 305-313.

Spirina, L. V., Avgustinovich, A. V., Bakina, O. V., Afanas’ ev, S. G., Volkov, M. Y., Vtorushin, S. V., ... & Munkuev, I. O. (2024). Targeted Sequencing in Gastric Cancer: Association with Tumor Molecular Characteristics and FLOT Therapy Effectiveness. Current Issues in Molecular Biology, 46(2), 1281-1290.

Takenaka, M., Saito, M., Iwakawa, R., Yanaihara, N., Saito, M., Kato, M., ... & Kohno, T. (2015). Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. International journal of oncology, 46(6), 2389-2398.

Wang, S.; Yang, X.; Liu, C.; Hu, J.; Yan, M.; Ding, C.; Fu, Y.(2023). Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer. Medicine , 102, e35111.

Xing M. (2007). BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications. Endocr Rev 28: 742-762.

Yoshimura A, Ito H, Nishino Y, et al. (2018). Recent improvement in the long-term survival of breast cancer patients by age and stage in Japan. J Epidemiol. 2018;28:420-427.




DOI: https://doi.org/10.30743/best.v7i2.10424

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.